Search

Your search keyword '"Toner, Mehmet"' showing total 1,537 results
Start Over Author "Toner, Mehmet"
1,537 results on '"Toner, Mehmet"'

2. Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells

Author

Dubash, Taronish D., Bardia, Aditya, Chirn, Brian, Reeves, Brittany A., LiCausi, Joseph A., Burr, Risa, Wittner, Ben S., Rai, Sumit, Patel, Hitisha, Bihani, Teeru, Arlt, Heike, Bidard, Francois-Clement, Kaklamani, Virginia G., Aftimos, Philippe, Cortés, Javier, Scartoni, Simona, Fiascarelli, Alessio, Binaschi, Monica, Habboubi, Nassir, Iafrate, A. John, Toner, Mehmet, Haber, Daniel A., and Maheswaran, Shyamala

Published
2023
Full Text
View/download PDF

8. VCA supercooling in a swine partial hindlimb model

Author

Berkane, Yanis, Filz von Reiterdank, Irina, Tawa, Pierre, Charlès, Laura, Goutard, Marion, Dinicu, Antonia T., Toner, Mehmet, Bertheuil, Nicolas, Mink van der Molen, Aebele B., Coert, J. Henk, Lellouch, Alexandre G., Randolph, Mark A., Cetrulo, Jr., Curtis L., and Uygun, Korkut

Published
2024
Full Text
View/download PDF

10. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs

Author

Guo, Hongshan, Vuille, Joanna A., Wittner, Ben S., Lachtara, Emily M., Hou, Yu, Lin, Maoxuan, Zhao, Ting, Raman, Ayush T., Russell, Hunter C., Reeves, Brittany A., Pleskow, Haley M., Wu, Chin-Lee, Gnirke, Andreas, Meissner, Alexander, Efstathiou, Jason A., Lee, Richard J., Toner, Mehmet, Aryee, Martin J., Lawrence, Michael S., Miyamoto, David T., Maheswaran, Shyamala, and Haber, Daniel A.

Published
2023
Full Text
View/download PDF

11. Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product

Author

Mishra, Avanish, primary, Huang, Shih-Bo, additional, Dubash, Taronish, additional, Burr, Risa, additional, Edd, Jon F., additional, Wittner, Ben S., additional, Cunneely, Quinn E., additional, Putaturo, Victor R., additional, Deshpande, Akansha, additional, Antmen, Ezgi, additional, Gopinathan, Kaustav A., additional, Otani, Keisuke, additional, Miyazawa, Yoshiyuki, additional, Kwak, Ji Eun, additional, Guay, Sara Y., additional, Kelly, Justin, additional, Walsh, John, additional, Nieman, Linda, additional, Galler, Isabella, additional, Chan, PuiYee, additional, Lawrence, Michael S., additional, Sullivan, Ryan J., additional, Bardia, Aditya, additional, Micalizzi, Douglas S., additional, Sequist, Lecia V., additional, Lee, Richard J., additional, Franses, Joseph W., additional, Ting, David T., additional, Brunker, Patricia A. R., additional, Maheswaran, Shyamala, additional, Miyamoto, David T., additional, Haber, Daniel A., additional, and Toner, Mehmet, additional

Published
2024
Full Text
View/download PDF

12. Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine

Author

Isiksacan, Ziya, primary, D’Alessandro, Angelo, additional, McKenna, David H., additional, Tessier, Shannon N., additional, Kucukal, Erdem, additional, Gokaltun, A. Aslihan, additional, William, Nishaka, additional, Sandlin, Rebecca D., additional, Bischof, John, additional, Mohandas, Narla, additional, Busch, Michael P., additional, Elbuken, Caglar, additional, Gurkan, Umut A., additional, Toner, Mehmet, additional, Acker, Jason P., additional, Yarmush, Martin L., additional, and Usta, O. Berk, additional

Published
2024
Full Text
View/download PDF

13. Optimization of liver graft function using poly-pharmacological drug cocktail CEPT in a simulated transplant model

Author

Kharga, Anil, primary, Mojoudi, Mohammadreza, additional, Chen, Huyun, additional, Taggart, McLean S., additional, Dinicu, Antonia T., additional, Ozgur, Ozge S., additional, Uygun, Basak, additional, Toner, Mehmet, additional, Tessier, Shannon N., additional, Yeh, Heidi, additional, Markmann, James F., additional, Longchamp, Alban, additional, and Uygun, Korkut, additional

Published
2024
Full Text
View/download PDF

14. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

Author

Saylor, Philip J., primary, Otani, Keisuke, additional, Balza, Rene, additional, Ukleja, Jacob, additional, Pleskow, Haley, additional, Fisher, Rebecca, additional, Kusaka, Erika, additional, Otani, Yukako S., additional, Badusi, Priscilla Oluwakemi, additional, Smith, Matthew R., additional, Meneely, Erika, additional, Olivier, Kara, additional, Lowe, Alarice C., additional, Toner, Mehmet, additional, Maheswaran, Shyamala, additional, Haber, Daniel A., additional, Yeap, Beow Y., additional, Lee, Richard J., additional, and Miyamoto, David T., additional

Published
2024
Full Text
View/download PDF

15. Partial freezing of rat livers extends preservation time by 5-fold

Author

Tessier, Shannon N., de Vries, Reinier J., Pendexter, Casie A., Cronin, Stephanie E. J., Ozer, Sinan, Hafiz, Ehab O. A., Raigani, Siavash, Oliveira-Costa, Joao Paulo, Wilks, Benjamin T., Lopera Higuita, Manuela, van Gulik, Thomas M., Usta, Osman Berk, Stott, Shannon L., Yeh, Heidi, Yarmush, Martin L., Uygun, Korkut, and Toner, Mehmet

Published
2022
Full Text
View/download PDF

16. 'Extreme' Microfluidics: Large-volumes and Complex Fluids

Author

Toner, Mehmet

Subjects
Physics - Fluid Dynamics, Quantitative Biology - Other Quantitative Biology
Abstract

Mehmet Toner is the Helen Andrus Benedict Professor of Biomedical Engineering at the Massachusetts General Hospital (MGH), Harvard Medical School, and Harvard - MIT Health Sciences & Technology. Here he describes his labs efforts to advance the field of microfluidics to process large-volumes of fluids. Although somewhat counterintuitive, this approach has found a broad interest in both academia and industry at an unprecedented rate due to its broad range of utility in medical and industrial applications., Comment: Nobel Symposium 162, Stockholm, Sweden, 2017 arXiv:1712.08369v1 Report-no: Nobel162/2017/09

Published
2018

24. The promise of organ and tissue preservation to transform medicine

Author

Giwa, Sebastian, Lewis, Jedediah K, Alvarez, Luis, Langer, Robert, Roth, Alvin E, Church, George M, Markmann, James F, Sachs, David H, Chandraker, Anil, Wertheim, Jason A, Rothblatt, Martine, Boyden, Edward S, Eidbo, Elling, Lee, WP Andrew, Pomahac, Bohdan, Brandacher, Gerald, Weinstock, David M, Elliott, Gloria, Nelson, David, Acker, Jason P, Uygun, Korkut, Schmalz, Boris, Weegman, Brad P, Tocchio, Alessandro, Fahy, Greg M, Storey, Kenneth B, Rubinsky, Boris, Bischof, John, Elliott, Janet AW, Woodruff, Teresa K, Morris, G John, Demirci, Utkan, Brockbank, Kelvin GM, Woods, Erik J, Ben, Robert N, Baust, John G, Gao, Dayong, Fuller, Barry, Rabin, Yoed, Kravitz, David C, Taylor, Michael J, and Toner, Mehmet

Subjects
Health Services and Systems, Biomedical and Clinical Sciences, Health Sciences, Cancer, Generic health relevance, Good Health and Well Being, Cryopreservation, Forecasting, Humans, Organ Culture Techniques, Organ Preservation, Organ Transplantation, Regenerative Medicine, Tissue Preservation
Abstract

The ability to replace organs and tissues on demand could save or improve millions of lives each year globally and create public health benefits on par with curing cancer. Unmet needs for organ and tissue preservation place enormous logistical limitations on transplantation, regenerative medicine, drug discovery, and a variety of rapidly advancing areas spanning biomedicine. A growing coalition of researchers, clinicians, advocacy organizations, academic institutions, and other stakeholders has assembled to address the unmet need for preservation advances, outlining remaining challenges and identifying areas of underinvestment and untapped opportunities. Meanwhile, recent discoveries provide proofs of principle for breakthroughs in a family of research areas surrounding biopreservation. These developments indicate that a new paradigm, integrating multiple existing preservation approaches and new technologies that have flourished in the past 10 years, could transform preservation research. Capitalizing on these opportunities will require engagement across many research areas and stakeholder groups. A coordinated effort is needed to expedite preservation advances that can transform several areas of medicine and medical science.

Published
2017

25. Zebrafish as a high throughput model for organ preservation and transplantation research

Author

Da Silveira Cavalcante, Luciana, primary, Lopera Higuita, Manuela, additional, González‐Rosa, Juan Manuel, additional, Marques, Beatriz, additional, To, Samantha, additional, Pendexter, Casie A., additional, Cronin, Stephanie E. J., additional, Gopinathan, Kaustav, additional, de Vries, Reinier J., additional, Ellett, Felix, additional, Uygun, Korkut, additional, Langenau, David M., additional, Toner, Mehmet, additional, and Tessier, Shannon N., additional

Published
2023
Full Text
View/download PDF

26. Anti-apoptotic treatment of warm ischemic male rat livers in machine perfusion improves symptoms of ischemia-reperfusion injury

Author

Mojoudi, Mohammadreza, primary, Taggart, McLean S., additional, Kharga, Anil, additional, Chen, Huyun, additional, Dinicu, Antonia T., additional, Wilks, Benjamin T., additional, Markmann, James F., additional, Toner, Mehmet, additional, Tessier, Shannon N., additional, Yeh, Heidi, additional, and Uygun, Korkut, additional

Published
2023
Full Text
View/download PDF

27. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis

Author

Zheng, Yu, Comaills, Valentine, Burr, Risa, Boulay, Gaylor, Miyamoto, David T., Wittner, Ben S., Emmons, Erin, Sil, Srinjoy, Koulopoulos, Michael W., Broderick, Katherine T., Tai, Eric, Rengarajan, Shruthi, Kulkarni, Anupriya S., Shioda, Toshi, Wu, Chin-Lee, Ramaswamy, Sridhar, Ting, David T., Toner, Mehmet, Rivera, Miguel N., Maheswaran, Shyamala, and Haber, Daniel A.

Published
2019

30. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.

Author

Shen, Keyue, Luk, Samantha, Hicks, Daniel F, Elman, Jessica S, Bohr, Stefan, Iwamoto, Yoshiko, Murray, Ryan, Pena, Kristen, Wang, Fangjing, Seker, Erkin, Weissleder, Ralph, Yarmush, Martin L, Toner, Mehmet, Sgroi, Dennis, and Parekkadan, Biju

Subjects
Microcirculation, Bone Marrow Cells, Cell Line, Tumor, Fibroblasts, Stromal Cells, Animals, Mice, Inbred NOD, Humans, Mice, Mice, SCID, Bone Neoplasms, Breast Neoplasms, Mammary Neoplasms, Experimental, Neoplasm Metastasis, Disease Progression, Morpholines, Purines, Collagen, Green Fluorescent Proteins, Ki-67 Antigen, Gene Expression Profiling, Neoplasm Transplantation, Signal Transduction, Gene Expression Regulation, Neoplastic, Phenotype, Female, Cell Line, Tumor, Inbred NOD, SCID, Mammary Neoplasms, Experimental, Gene Expression Regulation, Neoplastic, Cancer, Breast Cancer, 2.1 Biological and endogenous factors
Abstract

Tumour-stromal interactions are a determining factor in cancer progression. In vivo, the interaction interface is associated with spatially resolved distributions of cancer and stromal phenotypes. Here, we establish a micropatterned tumour-stromal assay (μTSA) with laser capture microdissection to control the location of co-cultured cells and analyse bulk and interfacial tumour-stromal signalling in driving cancer progression. μTSA reveals a spatial distribution of phenotypes in concordance with human oestrogen receptor-positive (ER+) breast cancer samples, and heterogeneous drug activity relative to the tumour-stroma interface. Specifically, an unknown mechanism of reversine is shown in targeting tumour-stromal interfacial interactions using ER+ MCF-7 breast cancer and bone marrow-derived stromal cells. Reversine suppresses MCF-7 tumour growth and bone metastasis in vivo by reducing tumour stromalization including collagen deposition and recruitment of activated stromal cells. This study advocates μTSA as a platform for studying tumour microenvironmental interactions and cancer field effects with applications in drug discovery and development.

Published
2014

32. Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications.

Author

Ouyang, Dongfang, Ye, Ningxin, Yang, Kun, Wang, Yiyang, Hu, Lina, Chao, Shuen, Toner, Mehmet, and Li, Yonghua

Subjects
BIOMARKERS, FLOW cytometry, CONFIDENCE intervals, CHRONIC myeloid leukemia, INDIVIDUALIZED medicine, DESCRIPTIVE statistics, RESEARCH funding, MICROFLUIDICS, CELL lines, LONGITUDINAL method
Abstract

Simple Summary: Chronic Myelogenous Leukemia (CML) is a common blood cancer that involves the uncontrolled growth of certain blood cells. Treating this disease effectively requires doctors to detect and eliminate even the smallest traces of cancer cells, a process known as managing minimal residual disease. However, current methods to find these cells, like bone marrow tests, are not only uncomfortable for patients but also have some drawbacks, such as missing cancer cells. This study introduces an innovative, less invasive approach using a microfluidic chip. This chip works by analyzing a patient's blood sample to find and measure the number of leukemia cells. We tested this device on 56 patients with CML and found that it could successfully identify these cancer cells in blood, with a high accuracy rate. This new method is promising because it is less invasive and more precise, making it easier to monitor how well a patient's treatment is working and to make better treatment decisions. This advancement could significantly improve the care and outcomes of people with CML, making a real difference in their lives. Chronic Myelogenous Leukemia (CML) is a prevalent hematologic malignancy characterized by the malignant transformation of myeloid cells and their proliferation in the peripheral blood. The management of CML poses significant challenges, particularly in detecting and eradicating minimal residual disease, which is crucial for preventing relapse and improving survival outcomes. Traditional minimal residual disease detection methods, such as bone marrow aspiration, are invasive and have limitations which include the potential for sampling errors and false negatives. This study introduces a novel label-free microfluidic chip designed for the segregation and recovery of circulating leukemia cells, offering a non-invasive liquid biopsy approach with potential applications in precision medicine. Over July 2021 to October 2023, we recruited 56 CML patients across various disease stages and collected blood samples for analysis using our microfluidic device. The device demonstrated high efficacy in isolating circulating leukemia cells, with an optimal capture efficiency of 78% at a sample flow rate of 3 mL/h. Our results indicate that the microfluidic device can efficiently segregate and quantify circulating leukemia cells, providing a detailed understanding of CML progression and treatment response. The significant reduction in circulating leukemia cell counts in patients in complete remission highlights the device's potential in monitoring treatment efficacy. Furthermore, the device's sensitivity in detecting minimal residual disease could offer a more reliable prognostic tool for therapeutic decision-making in CML management. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

33. Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine

Author

Isiksacan, Ziya, primary, D’Alessandro, Angelo, additional, Wolf, Susan M., additional, McKenna, David H., additional, Tessier, Shannon N., additional, Kucukal, Erdem, additional, Gokaltun, A. Aslihan, additional, William, Nishaka, additional, Sandlin, Rebecca D., additional, Bischof, John, additional, Mohandas, Narla, additional, Busch, Michael P., additional, Elbuken, Caglar, additional, Gurkan, Umut A., additional, Toner, Mehmet, additional, Acker, Jason P., additional, Yarmush, Martin L., additional, and Usta, O. Berk, additional

Published
2023
Full Text
View/download PDF

37. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy

Author

Hong, Xin, Sullivan, Ryan J., Kalinich, Mark, Kwan, Tanya Todorova, Giobbie-Hurder, Anita, Pan, Shiwei, LiCausi, Joseph A., Milner, John D., Nieman, Linda T., Wittner, Ben S., Ho, Uyen, Chen, Tianqi, Kapur, Ravi, Lawrence, Donald P., Flaherty, Keith T., Sequist, Lecia V., Ramaswamy, Sridhar, Miyamoto, David T., Lawrence, Michael, Toner, Mehmet, Isselbacher, Kurt J., Maheswaran, Shyamala, and Haber, Daniel A.

Published
2018

39. HIF1A signaling selectively supports proliferation of breast cancer in the brain

Author

Ebright, Richard Y., Zachariah, Marcus A., Micalizzi, Douglas S., Wittner, Ben S., Niederhoffer, Kira L., Nieman, Linda T., Chirn, Brian, Wiley, Devon F., Wesley, Benjamin, Shaw, Brian, Nieblas-Bedolla, Edwin, Atlas, Lian, Szabolcs, Annamaria, Iafrate, Anthony J., Toner, Mehmet, Ting, David T., Brastianos, Priscilla K., Haber, Daniel A., and Maheswaran, Shyamala

Published
2020
Full Text
View/download PDF

40. A Microfluidic Transistor for Liquid Signal Processing

Author

Gopinathan, Kaustav A., Mishra, Avanish, Mutlu, Baris R., Edd, Jon F., and Toner, Mehmet

Subjects
Article
Abstract

Microfluidics have enabled significant advances in molecular biology (1–3) , synthetic chemistry (4,5) , diagnostics (6,7) , and tissue engineering (8) . However, there has long been a critical need in the field to manipulate fluids and suspended matter with the precision, modularity, and scalability of electronic circuits (9–11) . Just as the electronic transistor enabled unprecedented advances in the control of electricity on an electronic chip, a microfluidic analogue to the transistor could enable improvements in the complex, scalable control of reagents, droplets, and single cells on an autonomous microfluidic chip. Prior works on creating a microfluidic analogue to the electronic transistor (12–14) could not replicate the transistor’s saturation behavior, which is crucial to perform analog amplification (15) and is fundamental to modern circuit design (16) . Here we exploit the fluidic phenomenon of flow-limitation (17) to develop a microfluidic element with flow-pressure characteristics completely analogous to the current-voltage characteristics of the electronic transistor. As this microfluidic transistor successfully replicates all of the key operating regimes of the electronic transistor (linear, cut-off and saturation), we are able to directly translate a variety of fundamental electronic circuit designs into the fluidic domain, including the amplifier, regulator, level shifter, logic gate, and latch. Finally, we demonstrate a “smart” particle dispenser that senses single suspended particles, performs liquid signal processing, and accordingly controls the movement of said particles in a purely fluidic system without electronics. By leveraging the vast repertoire of electronic circuit design, microfluidic transistor-based circuits are easy to integrate at scale, eliminate the need for external flow control, and enable uniquely complex liquid signal processing and single-particle manipulation for the next generation of chemical, biological, and clinical platforms.

Published
2023

42. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

Author

Kalinich, Mark, Bhan, Irun, Kwan, Tanya T., Miyamoto, David T., Javaid, Sarah, LiCausi, Joseph A., Milner, John D., Hong, Xin, Goyal, Lipika, Sil, Srinjoy, Choz, Melissa, Ho, Uyen, Kapur, Ravi, Muzikansky, Alona, Zhang, Huidan, Weitz, David A., Sequist, Lecia V., Ryan, David P., Chung, Raymond T., Zhu, Andrew X., Isselbacher, Kurt J., Ting, David T., Toner, Mehmet, Maheswaran, Shyamala, and Haber, Daniel A.

Published
2017

44. Abstract CT073: Efficacy of novel oral SERD elacestrant in fulvestrant-refractory hormone receptor-positive (HR+) breast cancer: a translational investigation

Author

Dubash, Taronish D., primary, Bardia, Aditya, additional, Chirn, Brian, additional, Reeves, Brittany A., additional, LiCausi, Joseph A., additional, Burr, Risa, additional, Wittner, Ben S., additional, Rai, Sumit, additional, Patel, Hitisha, additional, Bihani, Teeru, additional, Arlt, Heike, additional, Bidard, Francois-Clement, additional, Kaklamani, Virginia G., additional, Aftimos, Philippe, additional, Cortés, Javier, additional, Scartoni, Simona, additional, Binaschi, Monica, additional, Habboubi, Nassir, additional, Iafrate, A. John, additional, Toner, Mehmet, additional, Haber, Daniel A., additional, and Maheswaran, Shyamala, additional

Published
2023
Full Text
View/download PDF

45. Data from An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer

Author

Miyamoto, David T., primary, Lee, Richard J., primary, Kalinich, Mark, primary, LiCausi, Joseph A., primary, Zheng, Yu, primary, Chen, Tianqi, primary, Milner, John D., primary, Emmons, Erin, primary, Ho, Uyen, primary, Broderick, Katherine, primary, Silva, Erin, primary, Javaid, Sarah, primary, Kwan, Tanya Todorova, primary, Hong, Xin, primary, Dahl, Douglas M., primary, McGovern, Francis J., primary, Efstathiou, Jason A., primary, Smith, Matthew R., primary, Sequist, Lecia V., primary, Kapur, Ravi, primary, Wu, Chin-Lee, primary, Stott, Shannon L., primary, Ting, David T., primary, Giobbie-Hurder, Anita, primary, Toner, Mehmet, primary, Maheswaran, Shyamala, primary, and Haber, Daniel A., primary

Published
2023
Full Text
View/download PDF

46. Data from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

Author

Kwan, Tanya T., primary, Bardia, Aditya, primary, Spring, Laura M., primary, Giobbie-Hurder, Anita, primary, Kalinich, Mark, primary, Dubash, Taronish, primary, Sundaresan, Tilak, primary, Hong, Xin, primary, LiCausi, Joseph A., primary, Ho, Uyen, primary, Silva, Erin J., primary, Wittner, Ben S., primary, Sequist, Lecia V., primary, Kapur, Ravi, primary, Miyamoto, David T., primary, Toner, Mehmet, primary, Haber, Daniel A., primary, and Maheswaran, Shyamala, primary

Published
2023
Full Text
View/download PDF

47. Table S2 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

Author

Hong, Xin, primary, Roh, Whijae, primary, Sullivan, Ryan J., primary, Wong, Keith H.K., primary, Wittner, Ben S., primary, Guo, Hongshan, primary, Dubash, Taronish D., primary, Sade-Feldman, Moshe, primary, Wesley, Benjamin, primary, Horwitz, Elad, primary, Boland, Genevieve M., primary, Marvin, Dieuwke L., primary, Bonesteel, Todd, primary, Lu, Chenyue, primary, Aguet, François, primary, Burr, Risa, primary, Freeman, Samuel S., primary, Parida, Laxmi, primary, Calhoun, Katherine, primary, Jewett, Michelle K., primary, Nieman, Linda T., primary, Hacohen, Nir, primary, Näär, Anders M., primary, Ting, David T., primary, Toner, Mehmet, primary, Stott, Shannon L., primary, Getz, Gad, primary, Maheswaran, Shyamala, primary, and Haber, Daniel A., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Tables from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

Author

Kwan, Tanya T., primary, Bardia, Aditya, primary, Spring, Laura M., primary, Giobbie-Hurder, Anita, primary, Kalinich, Mark, primary, Dubash, Taronish, primary, Sundaresan, Tilak, primary, Hong, Xin, primary, LiCausi, Joseph A., primary, Ho, Uyen, primary, Silva, Erin J., primary, Wittner, Ben S., primary, Sequist, Lecia V., primary, Kapur, Ravi, primary, Miyamoto, David T., primary, Toner, Mehmet, primary, Haber, Daniel A., primary, and Maheswaran, Shyamala, primary

Published
2023
Full Text
View/download PDF

49. Data from AR Expression in Breast Cancer CTCs Associates with Bone Metastases

Author

Aceto, Nicola, primary, Bardia, Aditya, primary, Wittner, Ben S., primary, Donaldson, Maria C., primary, O'Keefe, Ryan, primary, Engstrom, Amanda, primary, Bersani, Francesca, primary, Zheng, Yu, primary, Comaills, Valentine, primary, Niederhoffer, Kira, primary, Zhu, Huili, primary, Mackenzie, Olivia, primary, Shioda, Toshi, primary, Sgroi, Dennis, primary, Kapur, Ravi, primary, Ting, David T., primary, Moy, Beverly, primary, Ramaswamy, Sridhar, primary, Toner, Mehmet, primary, Haber, Daniel A., primary, and Maheswaran, Shyamala, primary

Published
2023
Full Text
View/download PDF

50. Supplementary figures from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

Author

Kwan, Tanya T., primary, Bardia, Aditya, primary, Spring, Laura M., primary, Giobbie-Hurder, Anita, primary, Kalinich, Mark, primary, Dubash, Taronish, primary, Sundaresan, Tilak, primary, Hong, Xin, primary, LiCausi, Joseph A., primary, Ho, Uyen, primary, Silva, Erin J., primary, Wittner, Ben S., primary, Sequist, Lecia V., primary, Kapur, Ravi, primary, Miyamoto, David T., primary, Toner, Mehmet, primary, Haber, Daniel A., primary, and Maheswaran, Shyamala, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results